Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 282819, 7 pages
http://dx.doi.org/10.1155/2015/282819
Research Article

Survival of AIDS Patients Treated with Traditional Chinese Medicine in Rural Central China: A Retrospective Cohort Study, 2004–2012

1Department of AIDS Treatment and Research Center, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 45000, China
2National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
3School of International Education, Zhengzhou Railway Vocational and Technical College, Zhengzhou 450000, China
4Key Laboratory of Viral Diseases Prevention and Treatment of Traditional Chinese Medicine of Henan Province, Zhengzhou 450000, China

Received 31 October 2014; Revised 29 November 2014; Accepted 30 November 2014

Academic Editor: Mani Vasudevan

Copyright © 2015 Yantao Jin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS, “Fact sheet 2014: globle statistics,” http://www.unaids.org/en/media/unaids/contentassets/documents/factsheet/2014/20140716_FactSheet_en.pdf.
  2. Y. Jin, Z. Liu, X. Wang et al., “A systematic review of cohort studies of the quality of life in HIV/AIDS patients after antiretroviral therapy,” International Journal of STD & AIDS, vol. 25, no. 11, pp. 771–777, 2014. View at Google Scholar
  3. J.-J. Parienti, K. Ragland, F. Lucht et al., “Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication,” Clinical Infectious Diseases, vol. 50, no. 8, pp. 1192–1197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. O. Ramadhani, N. M. Thielman, K. Z. Landman et al., “Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania,” Clinical Infectious Diseases, vol. 45, no. 11, pp. 1492–1498, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Liu, J. Yang, H. Liu, and Y. Jin, “Factors associated with fatigue in acquired immunodeficiency syndrome patients with antiretroviral drug adverse reactions: a retrospective study,” Journal of Traditional Chinese Medicine, vol. 33, no. 3, pp. 316–321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. K. Sethi, D. D. Celentano, S. J. Gange, R. D. Moore, and J. E. Gallant, “Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance,” Clinical Infectious Diseases, vol. 37, no. 8, pp. 1112–1118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Z.-B. Liu, X. Wang, H.-J. Liu et al., “Treatment of acquired immunodeficiency syndrome with chinese medicine in China: opportunity, advancement and challenges,” Chinese Journal of Integrative Medicine, vol. 19, no. 8, pp. 563–567, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Dou, R. Y. Chen, Z. Wang et al., “HIV-infected former plasma donors in rural central China: from infection to survival outcomes, 1985–2008,” PLoS ONE, vol. 5, no. 10, Article ID e13737, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Zhang, J. E. Haberer, Y. Wang et al., “The Chinese free antiretroviral treatment program: challenges and responses,” AIDS, vol. 21, supplement 8, pp. S143–S148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Ministry of Health of the People's Republic of China, “2012 China AIDS Response Progress Report,” 2012, http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_CN_Narrative_Report[1].pdf.
  11. R. R. Allam, M. V. Murhekar, T. Bhatnagar et al., “Survival probability and predictors of mortality and retention in care among patients enrolled for first-line antiretroviral therapy,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 108, no. 4, pp. 198–205, 2008. View at Google Scholar
  12. I. Sieleunou, M. Souleymanou, A.-M. Schönenberger, J. Menten, and M. Boelaert, “Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon,” Tropical Medicine and International Health, vol. 14, no. 1, pp. 36–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Mageda, G. H. Leyna, and E. J. Mmbaga, “High initial HIV/AIDS-Related mortality and -its predictors among patients on antiretroviral therapy in the kagera region of Tanzania: a five-year retrospective cohort study,” AIDS Research and Treatment, vol. 2012, Article ID 843598, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. D.-Y. Sun, Q. Wang, W.-J. Yang, Q. Zhu, and Z. Wang, “Survival analysis on AIDS antiretroviral therapy in Henan province during 2003–2009,” Zhong Huan Liu Xing Bing Xue Za Zhi, vol. 33, no. 2, pp. 181–184, 2012. View at Google Scholar · View at Scopus
  15. L. Bhatta, E. Klouman, K. Deuba et al., “Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in far-western Region, 2006–2011,” BMC Infectious Diseases, vol. 13, no. 1, article 604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Jin, Z. Liu, X. Chen et al., “Survival of people living with HIV after treatment with traditional Chinese medicine in Henan province of China: a retrospective cohort study,” Journal of Traditional Chinese Medicine, vol. 34, no. 4, pp. 430–436, 2014. View at Google Scholar
  17. A. I. van Sighem, M. A. van de Wiel, A. C. Ghani et al., “Mortality and progression to AIDS after starting highly active antiretroviral therapy,” AIDS, vol. 17, no. 15, pp. 2227–2236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Rapiti, D. Porta, F. Forastiere, D. Fusco, and C. A. Perucci, “Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy,” Epidemiology, vol. 11, no. 5, pp. 496–501, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. E. J. Fordyce, T. P. Singh, D. Nash, B. Gallagher, and S. Forlenza, “Survival rates in NYC in the era of combination ART,” Journal of Acquired Immune Deficiency Syndromes, vol. 30, no. 1, pp. 111–118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Z. Li, L. R. Xu, M. L. Zhang, and J. Z. Guo, “Clinical observation on885AIDS patients treated by Yiaikang capsule combined with treatment based on syndrome differentiation,” Zhong Yi Za Zhi, vol. 51, no. 9, pp. 808–810, 2010. View at Google Scholar
  21. L. R. Xu, F. Z. Li, Y. He, J. Z. Guo, and D. Wang, “Sixty-month clinical observation of HIV carriers/AIDS patients treated with Yiaikang capsule in terms of theirs CD+4T cell counts and viral load,” Zhong Guo Ai Zi Bing Xing Bing, vol. 3, no. 3, pp. 231–233, 2010. View at Google Scholar
  22. M. Cornell, M. Schomaker, D. B. Garone et al., “Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study,” PLoS Medicine, vol. 9, no. 9, Article ID e1001304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Taylor-Smith, H. Tweya, A. Harries, E. Schoutene, and A. Jahn, “Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi,” Malawi Medical Journal, vol. 22, no. 2, pp. 49–56, 2010. View at Google Scholar · View at Scopus
  24. S. Kanters, M. Nansubuga, D. Mwehire et al., “Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda,” Journal of HIV/AIDS (Auckland), vol. 5, pp. 111–119, 2013. View at Google Scholar
  25. S. Zeng and L. Lin, “Study on smoking pattern and related factors among residents aged over 15 years in Guangdong province,” Zhonghua Liu Xing Bing Xue Za Zhi, vol. 21, no. 2, pp. 134–136, 2000. View at Google Scholar · View at Scopus
  26. X. B. Yang, X. Q. Liu, D. B. Wang, C. B. Xue, J. Cheng, and J. Chai, “Analysis of the inf luencing factor and epidemic trend of urban and rural residents frequency of drinking in JiangsuProvince,” Zhong Hua Ji Bing Kong Zhi Za Zhi, vol. 15, no. 6, pp. 503–506, 2011. View at Google Scholar
  27. C. Bakanda, J. Birungi, R. Mwesigwa et al., “Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy,” AIDS, vol. 25, no. 5, pp. 701–705, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Youmans, A. Tripathi, J. J. Gibson, T. Stephens, and W. A. Duffus, “Demographic characteristics and behavioral risk factors of HIV infection and association with survival among individuals 50 years or older,” Southern Medical Journal, vol. 104, no. 10, pp. 669–675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. J. Mills, C. Bakanda, J. Birungi, S. Yaya, and N. Ford, “The prognostic value of baseline CD4+ cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting,” AIDS, vol. 26, no. 11, pp. 1425–1429, 2012. View at Publisher · View at Google Scholar · View at Scopus